metastatic hormone positive breast cancer | 2023 ku breast cancer year in review conference
Published 1 year ago • 3.7K plays • Length 26:08Download video MP4
Download video MP3
Similar videos
-
30:22
adjuvant therapy | 2023 ku breast cancer year in review conference
-
25:20
her2 low breast cancer a new therapeutic subtype | 2023 ku breast cancer year in review conference
-
5:19
historical perspective on hr /her2- breast cancer: 2023 ku breast cancer year in review
-
2:24
hot topics for case discussion in breast cancer: 2023 ku breast cancer year in review
-
1:25
breast cancer molecular testing – more tools in the toolbox: 2023 ku breast cancer year in review
-
2:56
on the role of molecular tumor profiling in breast cancer: 2023 ku breast cancer year in review
-
2:23
preserving fertility, and genomic assays in breast cancer: 2023 ku breast cancer year in review
-
22:57
2022 west oncology conference | breast cancers | metastatic
-
0:50
attend the 2023 breast cancer year in review | priyanka sharma, md & jennifer klemp, phd, mph, ma
-
2:06
antibody-drug conjugates for her2-low disease: 2023 ku breast cancer year in review
-
2:43
sequencing treatment options in her2 positive breast cancer: 2023 best of breast conference
-
1:34
updates in metastatic breast cancer: 2023 west oncology
-
26:14
metastatic breast cancer | 2022 oneoncology conference
-
6:29
hot topics in advanced breast cancer: 2023 best of breast conference
-
20:55
lightning updates | 2023 best of breast conference
-
1:02:59
case-based clinical updates in breast cancer | 2023 community cases memphis
-
3:03
radiation after lumpectomy – determining who benefits: 2023 ku breast cancer year in review
-
46:31
adjuvant therapy | 2023 best of breast conference